Authors



Matthew Sussman, MA

Latest:

Resource Use Among Nonvalvular Atrial Fibrillation Patients

This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.


Jennifer L. Hofmann, DMSC, MS, PA-C

Latest:

Clinicians, Pharmacists Should Work to Ensure Safety Compounded GLP-1 Medications

Pharmacists can educate patients about how to recognize unsafe online sources of medications and ensure patients are properly educate on how to administer their medications.



T. Mitchell James, III

Latest:

Not Just a Generic: Specialty Pharmacy Considerations for a Biosimilar Launch

As new biosimilars enter the market, pharmacies should carefully consider infrastructure, resources, and strategies for successfully integrating the products into their portfolio of offerings.



Joshua Pirestani

Latest:

Why Some Supplements Are Fraudulent and Harmful

The FDA is not authorized to review the safety and efficacy of dietary supplement products before they are sold on the market.


Deeb D. Eid, PharmD, FMPLP

Latest:

Standard of Care: The No. 1 Priority to Ensure Success in Pharmacy Practice’s Future

SOC emphasizes adaptability and individual professional judgment without compromising quality as individuals are held to the standard and expertise of their practice area



Mary Inguanti, RPh, MPH, FASCP

Latest:

Community Health Centers: A Pharmacist's Perspective

By focusing on primary healthcare, community health centers keep down healthcare costs for all consumers, taxpayers, and governments.



Dave Domann, RPh, MS

Latest:

Applying Value-Based Incentive Models Within Community Pharmacy Practice

Healthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.



Chris Chan, PharmD

Latest:

Applying Value-Based Incentive Models Within Community Pharmacy Practice

Healthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.



Allison Gilchrist, Associate Editor

Latest:

Generic Biologic Drugs Appear Equivalent to Brand Name Counterpart

A recent analysis from Johns Hopkins University Bloomberg School of Public Health researchers found that generic forms of the biologic drug infliximab (remicade) appear to be just as safe and effective as the brand name version.


Timothy O'Shea, PharmD

Latest:

Clinical Insights: Zolgensma for Spinal Muscular Atrophy

Zolgensma is the first gene therapy indicated for the treatment of children with spinal muscular atrophy.


Tara Menkhaus, Pharm D Candidate, University of Cincinnati James L. Winkle College of Pharmacy

Latest:

Pursuing Specialty Pharmacy Accreditation

Selecting an accreditation agency should be determined by the local business environment and needs.


Timothy G. Ferris, MD, MPH

Latest:

Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL Control

Evaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.


Meybel Morales, PharmD

Latest:

Does Prioritizing Self-Care Mean Betraying Your Patient Care?

According to the results of a nationwide survey conducted among clinical pharmacists, too many working hours is the major factor causing burnout, followed by inadequate management.


Fonda Shu-Ayanji, PharmD/MPH Candidate

Latest:

Developing a Framework for Delivery of Medication Therapy Management in a Specialty Pharmacy

Pharmacists are central health care professionals in medication therapy management and play a crucial role in improving life quality outcomes among patients.




Ihor Vasyutyn

Latest:

Precision Medicine and the 21st Century Cures Act

The 21st Century Cures Act will have a huge impact on the pharmaceutical industry both nationally and globally.



John K. McGuirk, MAEd, MBA

Latest:

Fast Forward: Evolutionary Changes Ahead for Community Pharmacy

The growing trend of accountable care organizations gives pharmacists the chance to make a greater impact on the health of their patients in a team approach that saves both dollars and lives.


Jenny Shan, PharmD Candidate 2018

Latest:

Taking on AMCP Nexus: A First-Time Conference Experience

As one of Academy of Managed Care Pharmacy’s two annual conventions, AMCP Nexus aims to provide in-depth educational programming on the current advances and challenges in managed care.


Conchetta Lesser, PharmD, BCACP

Latest:

Vaccine Billing Coverage Options: Seasonal Influenza and Future COVID-19 Vaccines

A thorough understanding of immunization billing processes for Medicare, Medicaid, and other third-party payers will be critical to ensure pharmacy staff can efficiently serve their communities and facilitate a smooth reimbursement process.


Rare Disease Report Staff

Latest:

Genzyme's Lumizyme Now Indicated for Infantile-Onset Pompe Disease

FDA will no longer require Genzyme to continue the Risk Evaluation and Mitigation Strategy program.